Scienmag

FEBRUARY 23, 2021

Scientists discover complex and dynamic bacterial ecosystem in human breast milk using genomic technology pioneered for the International Space Station Credit: Emmanuel Gonzalez et al.

Bacteria 52

Bacteria Genome Genomics Scientist 52

Scienmag

APRIL 29, 2021

In short, the virus’ genome gets tagged with a […].

Immune Response 52

Immune Response Genome Genomics Medicine 52

Roots Analysis

AUGUST 31, 2023

Nutrigenomics is the science studying the relationship between human genome, nutrition and health. In part, the success of the Human Genome Project has also paved a path for the novel concept of nutrigenomics. Nutritional DNA testing helps in identifying foods that might lead to allergies or intolerance in an individual.

Genomics 40

Genomics Genome Genetics Gene 40

Roots Analysis

MARCH 16, 2023

The following points illustrate the key applications of mRNA therapeutics and vaccines: Allergy Tolerization Therapies: Plasmid DNA and mRNA vaccines that encode for allergens have been demonstrated to be capable of inducing T helper 1 cells and T regulatory responses, which, in turn, can modulate allergic reactions caused due to T helper 2 cells.

Vaccine 52

Vaccine Vaccination DNA Protein 52

XTalks

NOVEMBER 30, 2023

These dual gRNAs target three specific sites within the HIV genome, facilitating the removal of substantial portions of the viral DNA and minimizing the potential for viral escape. The noteworthy candidate, EBT-101, is designed to eliminate HIV proviral DNA using CRISPR-Cas9 along with two guide RNAs (gRNAs).

FDA Approval 111

FDA Approval Gene Therapy Gene Clinical Trials 111

Scienmag

JUNE 22, 2021

For the study, investigators analyzed 7,548 SARS-CoV-2 genomes of COVID-19 patients worldwide […]. A new study published in Genetic Epidemiology has examined the genetic code of SARS-CoV-2 viruses that have infected patients, looking for links between different mutations and patient deaths.

Genetics 40

Genetics Genome Genomics Research 40

The Pharma Data

DECEMBER 14, 2020

government’s Operation Warp Speed, Moderna has been working with the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID). With the Pfizer vaccine, there were two cases of severe anaphylactic shock in the UK in people who had severe allergies and carried EpiPens. They have since recovered.

Vaccine 52

Vaccine Vaccination Allergies Genomics 52

Delveinsight

AUGUST 27, 2020

The phase 1 study that is being run by the National Institute of Allergy and Infectious Diseases tests three dose levels of the vaccine, mRNA-1273, given in two injections a month apart in 120 adults. Moderna showed robust phase 1 results for its COVID-19 vaccine in adults up to 55 last month.

Vaccination 53

Vaccination Vaccine Research Trials 53

The Pharma Data

DECEMBER 17, 2020

But Forbes, an assistant professor of pediatrics, immunology, allergy and rheumatology at Baylor College of Medicine in Houston, said the patient’s diabetes appears to have been reversed. Because he had multiple conditions, his doctors ordered whole genome sequencing to see if they could pinpoint a root cause.

Insulin 52

Insulin Genetics Doctor Doctors 52

The Pharma Data

FEBRUARY 22, 2021

Thanks to its R&D agreement with Pairwise , the Broad Institute and others, Bayer has access to the best genome editing tools. Bayer’s research collaboration with the French biotech company Meiogenix is also accelerating the development of proprietary technologies related to plant breeding and genome editing applications.

Gene Editing 40

Gene Editing Genomics Genome Protein 40

XTalks

MARCH 18, 2024

Real-World Applications of Precision Fermentation Precision fermentation is at the forefront of creating alternative proteins and dairy products, providing solutions for vegetarians, vegans and those with dairy allergies.

Genetic Engineering 52

Genetic Engineering Genetics Production Protein 52

The Pharma Data

JANUARY 24, 2021

It inked a deal with the National Institute of Allergy and Infectious Diseases (NIAID) to launch a Phase I trial. National Institute of Allergy and Infectious Diseases (NIAID), of bamlanivimab (LY-CoV555) decreased the risk of COVID-19 among residents and staff of long-term care facilities, i.e., nursing homes.

Trials 52

Trials Allergies In-Vitro Antibody 52

XTalks

OCTOBER 26, 2023

An RNA genome enables the genetic material to mutate more rapidly. Some of the vaccines are already in clinical trials, including a universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health (NIH).

Vaccine 105

Vaccine Vaccination RNA Manufacturing 105

Pfizer

NOVEMBER 2, 2022

This is reminiscent of influenza, another respiratory disease that requires repeated vaccinations due to its genomic instability resulting in modifications of the surface protein hemagglutinin. Tell your vaccination provider about all of your medical conditions, including if you: have any allergies. have a fever.

Vaccine 85

Vaccine Vaccination Clinical Trials Clinical Trials 85

XTalks

DECEMBER 24, 2020

From isolating SARS-CoV-2 in early January to sequencing its genome shortly thereafter and having a prototype vaccine against it within days, scientific process and progress have held steadfast throughout the pandemic. CRISPR are found in approximately 50 percent of sequenced bacterial genomes and nearly 90 percent of archaea genomes.

Life Science 111

Life Science Vaccination Vaccine Gene 111

The Pharma Data

DECEMBER 22, 2020

National Institute of Allergy and Infectious Diseases, said Monday. Instead, it may have been identified there first because the British government has a strong monitoring system that has tracked tens of thousands of genomic sequences of virus samples. National Institute of Allergy and Infectious Diseases.

Packaging 52

Packaging Packaging Vaccine Vaccination 52

The Pharma Data

JANUARY 12, 2021

. “It could be — a possibility — that we have our own mutant that’s being more easily transmissible,” Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Monday. “We don’t know. We’re looking for it. ” On Monday, the U.S.

Vaccine 52

Vaccine Vaccination Scientist Allergies 52

The Pharma Data

JANUARY 13, 2021

. “It could be — a possibility — that we have our own mutant that’s being more easily transmissible,” Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Monday. “We don’t know. We’re looking for it. ” The U.S. ” The U.S.

Vaccination 52

Vaccination Vaccine Scientist Production 52

The Pharma Data

DECEMBER 23, 2020

“We don’t know that for absolutely certain, but it is reasonable to assume that is going on,” Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Monday. As the Pfizer and Moderna vaccines are shipped across the country, U.S. “It very well might be here for all we know.”

Vaccine 52

Vaccine Vaccination Allergies Nurses 52

The Pharma Data

DECEMBER 29, 2020

National Institute of Allergy and Infectious Diseases, said last week. Instead, it may have been identified there first because the British government has a strong monitoring system that has tracked tens of thousands of genomic sequences of virus samples. “It very well might be here for all we know.”

Clinical Trials 52

Clinical Trials Clinical Trials Vaccine Vaccination 52

The Pharma Data

DECEMBER 28, 2020

National Institute of Allergy and Infectious Diseases, said last week. Instead, it may have been identified there first because the British government has a strong monitoring system that has tracked tens of thousands of genomic sequences of virus samples. “It very well might be here for all we know.”

Vaccine 52

Vaccine Vaccination Scientist Allergies 52